Clinical Trial Update: TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer [Phase 1]

View source ↗

Summary

Phase 1 interaction study evaluating bedaquiline (TMC207) with lopinavir/ritonavir in healthy volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Kaletra (lopinavir)
• TMC207 (bedaquiline)

Snippet

Sponsor: Tibotec BVBA | Conditions: Tuberculosis, HIV | Phase 1 | Status: COMPLETED